Project Grant R03DK147338
- Federal Project Grant Award Summary The Beckman Research Institute of the City of Hope received a $178,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026 through April 30, 2028. This award supports fundamental and translational research focused on understanding stress response pathways in Type 1 Diabetes (T1D) through...
- Federal Grant Award Summary The Beckman Research Institute of the City of Hope received a $153,554 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with a completion date of July 31, 2030. The award funds research on alpha cell heterogeneity and its implications for Type 1 Diabetes (T1D) therapy development. The principal...
- Federal Project Grant Award Summary The Beckman Research Institute of the City of Hope received $868,670 in funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for research on beta cell regeneration therapy in Type 1 Diabetes (T1D). The award, effective February 15, 2026, and concluding December 31, 2030, funds preclinical research exploring combination therapeutic...
- Federal Grant Award Summary The Beckman Research Institute of the City of Hope received a $2.16 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period May 1, 2026, through April 30, 2029. The research project, titled "Circulating Extracellular Vesicles as a Marker of Human Type 1 Diabetes Pathogenesis," will investigate circulating...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1.45 million Project Grant to Beckman Research Institute of the City of Hope, effective August 20, 2025, through June 30, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award funds fundamental and translational research investigating chromatin remodeling factors and mechanisms in diabetic microvascular complications. The...
- Summary of Federal Project Grant Award The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Beckman Research Institute of the City of Hope $1,264,088 on July 21, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to fund research on epigenetic regulation of genomic stability in beta-cell homeostasis. The project, which extends through April 30, 2030, addresses critical gaps in understanding how pancreatic beta...
- Federal Grant Award Summary The Beckman Research Institute of the City of Hope received a $140,116 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with a completion date of July 31, 2028. The award supports fundamental research investigating the mechanisms of intestine-white adipose tissue (WAT) crosstalk in metabolic...
- Grant Award Summary The Beckman Research Institute of the City of Hope received a $847,746 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the five-year period commencing September 1, 2025 through August 31, 2030. The research project, titled "Role of UPR Transducer XBP1 in Pancreatic Beta Cell Survival and Function Under Metabolic Stress,"...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Scripps Research Institute a $801,662 Project Grant effective August 15, 2025, through June 30, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project investigates the initiation of anti-islet autoimmunity in Type 1 Diabetes (T1D), a CD4 T cell-mediated autoimmune disease, with particular focus on understanding the role...
- Federal Grant Award Summary The Beckman Research Institute of the City of Hope received a $849,788 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for research investigating the role of hyaluronan in beige adipogenesis. The award, obligated on September 5, 2025, with a completion date of June 30, 2030, supports basic and clinical biomedical research aimed at...
The Beckman Research Institute of the City of Hope received a $178,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026, through April 30, 2028. The award funds research investigating how the native pancreatic microenvironment regulates human islet cell function in health and Type 1 Diabetes (T1D). The primary deliverables include comparative functional and imaging analyses of hormone secretion and calcium signaling between intact human pancreatic tissue slices and isolated islets from matched donors, with separate cohorts of T1D and non-diabetic participants. The research project produces two primary outputs: quantification of the physiological impact of removing islets from their native tissue context by comparing endocrine cell responses to stimuli across paired tissue models, and identification of specific paracrine signals from non-endocrine cells (acinar, ductal, vascular, and neuronal) that influence islet cell activity. The findings are designed to advance understanding of how tissue context affects islet biology, provide validation of widely-used isolated islet research models, and generate evidence-based insights to support development of more physiologically relevant human islet models for disease research and therapeutic development targeting diabetes treatment and prevention.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 4/30/26 | ||
| Not listed | $178.0k | 4/29/26 |